By Zachary Brennan

The move by Pfizer continues the company’s push to publicly distance itself from the presidential race.

The move by Pfizer continues the company’s push to publicly distance itself from the presidential race.

The move by Pfizer continues the company’s push to publicly distance itself from the presidential race.

The move by Pfizer continues the company’s push to publicly distance itself from the presidential race.

The agency’s decision to hold vaccine developers to the stricter criteria will likely push any vaccine authorization beyond Election Day.

The agency’s decision to hold vaccine developers to the stricter criteria will likely push any vaccine authorization beyond Election Day.

The agency’s decision to hold vaccine developers to the stricter criteria will likely push any vaccine authorization beyond Election Day.

Monoclonal antibodies are a potential treatment that could combat Covid outbreaks before and after a safe and effective vaccine is widely available.

Monoclonal antibodies are a potential treatment that could combat Covid outbreaks before and after a safe and effective vaccine is widely available.

Monoclonal antibodies are a potential treatment that could combat Covid outbreaks before and after a safe and effective vaccine is widely available.

Monoclonal antibodies are a potential treatment that could combat Covid outbreaks before and after a safe and effective vaccine is widely available.

Monoclonal antibodies are a potential treatment that could combat Covid outbreaks before and after a safe and effective vaccine is widely available.

Several bioethicists question Rep. Andy Harris’ lack of experience.

Several bioethicists question Rep. Andy Harris’ lack of experience.

Several bioethicists question Rep. Andy Harris’ lack of experience.

Several bioethicists question Rep. Andy Harris’ lack of experience.

Several bioethicists question Rep. Andy Harris’ lack of experience.

The government initiative aims to provide 300 million doses of a Covid-19 vaccine by January 2021.

The government initiative aims to provide 300 million doses of a Covid-19 vaccine by January 2021.

The government initiative aims to provide 300 million doses of a Covid-19 vaccine by January 2021.

The government initiative aims to provide 300 million doses of a Covid-19 vaccine by January 2021.

The government initiative aims to provide 300 million doses of a Covid-19 vaccine by January 2021.

The government initiative aims to provide 300 million doses of a Covid-19 vaccine by January 2021.

The government initiative aims to provide 300 million doses of a Covid-19 vaccine by January 2021.

The government initiative aims to provide 300 million doses of a Covid-19 vaccine by January 2021.

Neither the companies nor the U.S. government bankrolling a great deal of the vaccine research has defined precisely what forgoing a profit means or how long that will last.

Neither the companies nor the U.S. government bankrolling a great deal of the vaccine research has defined precisely what forgoing a profit means or how long that will last.

Lawmakers want more transparency about $4 billion government investments.

The treatment advanced through an early safety study and is now being studied in a 2,000-patient Phase III trial.

That puts the price of a five-day treatment course at $2,340 per patient for people enrolled in federal health programs.